Testing effectiveness (Phase 2)Study completedNCT00002126
What this trial is testing
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Who this might be right for
HIV InfectionsCytopenias
Amgen 250